期刊
RESVERATROL AND HEALTH
卷 1215, 期 -, 页码 103-108出版社
WILEY-BLACKWELL
DOI: 10.1111/j.1749-6632.2010.05865.x
关键词
stilbenoid; Alzheimer's disease; beta-amyloid peptide; inhibition of aggregation
Stilbenoid compounds consist of a family of resveratrol derivatives. They have demonstrated promising activities in vitro and in vivo that indicate they may be useful in the prevention of a wide range of pathologies, such as cardiovascular diseases and cancers, as well have anti-aging effects. More recently stilbenoid compounds have shown promise in the treatment and prevention of neurodegenerative disorders, such as Huntington's, Parkinson's, and Alzheimer's diseases. This paper primarily focuses on the impact of stilbenoids in Alzheimer's disease and more specifically on the inhibition of beta-amyloid peptide aggregation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据